Frontage Holdings Past Earnings Performance

Past criteria checks 0/6

Frontage Holdings's earnings have been declining at an average annual rate of -5.1%, while the Life Sciences industry saw earnings growing at 14.1% annually. Revenues have been growing at an average rate of 22.8% per year. Frontage Holdings's return on equity is 1.7%, and it has net margins of 2.3%.

Key information

-5.1%

Earnings growth rate

-8.5%

EPS growth rate

Life Sciences Industry Growth	21.5%
Revenue growth rate	22.8%
Return on equity	1.7%
Net Margin	2.3%
Last Earnings Update	30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Frontage Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:FGHQ.F Revenue, expenses and earnings (USD Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
30 Jun 24	260	6	54	6
31 Mar 24	260	8	53	6
31 Dec 23	260	11	52	6
30 Sep 23	260	14	53	6
30 Jun 23	260	17	54	5
31 Mar 23	255	22	53	5
31 Dec 22	250	26	52	4
30 Sep 22	234	24	50	3
30 Jun 22	218	23	47	3
31 Mar 22	201	20	43	3
31 Dec 21	184	18	39	2
30 Sep 21	172	20	34	2
30 Jun 21	160	22	30	2
31 Mar 21	143	19	27	2
31 Dec 20	126	17	24	2
30 Sep 20	114	15	24	2
30 Jun 20	101	14	24	2
31 Mar 20	101	16	23	2
31 Dec 19	100	18	21	2
30 Sep 19	98	18	18	1
30 Jun 19	96	18	15	1
31 Mar 19	89	14	14	1
31 Dec 18	83	11	14	2
31 Dec 17	70	10	10	1
31 Dec 16	49	7	9	0

Quality Earnings: FGHQ.F has a large one-off loss of $3.0M impacting its last 12 months of financial results to 30th June, 2024.

Growing Profit Margin: FGHQ.F's current net profit margins (2.3%) are lower than last year (6.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: FGHQ.F's earnings have declined by 5.1% per year over the past 5 years.

Accelerating Growth: FGHQ.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: FGHQ.F had negative earnings growth (-64.9%) over the past year, making it difficult to compare to the Life Sciences industry average (-10.8%).

Return on Equity

High ROE: FGHQ.F's Return on Equity (1.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/09/18 01:39
End of Day Share Price	2024/06/21 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Frontage Holdings Corporation is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Bo Li	BofA Global Research
Bo Li	CLSA
Ziyi Chen	Goldman Sachs